-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression

By Folkmane I.   Chapenko S.   Amerika D.   Bicans J.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2384-2385

Elsevier

Access to resources Recommend Favorite

First Results With a Quadruple Therapy Regimen Including Tacrolimus and Mycophenolate Mofetil in Patients After Combined Pancreas and Kidney Transplantation

By Kahl A.   Bechstein W.O.   Platz K.   Muller A.   Berweck S.   Venz S.   Neuhaus P.   Frei U.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 505-506

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of FK 506 and Mycophenolic Acid After the Administration of a FK 506-Based Regimen in Combination With Mycophenolate Mofetil in Kidney Transplantation

By Undre N.A.   van Hooff J.   Christiaans M.   Vanrenterghem Y.   Donck J.   Heeman U.   Kohnle M.   Zanker B.   Land W.   Morales J.M.   Andres A.   Schafer A.   Stevenson P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1299-1302

Elsevier

Access to resources Recommend Favorite

Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study

By Zanker B.   Rothenpieler U.   Kubitza A.   Schneeberger H.   Hillebrand G.   Land W.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1142-1143

Elsevier

Access to resources Recommend Favorite

Immunosuppressive therapy and kaposi's sarcoma after kidney transplantation

By Moray G.   Basaran O.   Yagmurdur M.C.   Emiroglu R.   Bilgin N.   Haberal M.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 168-170

Elsevier

Access to resources Recommend Favorite